ATP-sensitive potassium channels mediate the anti-ischemic properties of ischemic and pharmacologic preconditioning in rat random-pattern skin flap

Ann Plast Surg. 2006 Jul;57(1):94-9. doi: 10.1097/01.sap.0000214872.13634.d4.

Abstract

Ischemic preconditioning (IPC) and pharmacologic preconditioning by morphine and adenosine may significantly decrease the amount of necrosis in rat random pattern skin flaps. We examined the role of ATP-sensitive potassium channels (K(ATP) channels) in mediating these protective phenomenon by using glibenclamide a nonspecific blocker of these channels. We also investigated whether administration of diazoxide an opener of the K(ATP) channels could mimic the same protective effect. Ninety male Sprague-Dawley rats were randomly divided into either control or treatment groups (n = 6 each). Bipedicled dorsal skin flaps (2 x 8 cm) were elevated at the midline. In pharmacologic preconditioning groups, 1 mL of morphine (5 mg/flap), adenosine (0.5 mg/flap), or different doses of diazoxide (0.5, 1, 5, and 15 mg/flap) were administered locally in the cranial half of the flap, respectively. One milliliter of saline was locally injected in the control group. In the IPC group, 1 hour after local saline injection the cranial pedicle was clamped for 20 minutes, and then 40 minutes' reperfusion was performed. In another experiment, 0.3 mg/kg of glibenclamide was injected intraperitoneally 30 minutes before local administration of saline or drug in ischemic or pharmacologic preconditioning groups. Regardless of the group, all flaps were cut at the cranial side 2 hours after elevation and were sutured back. Flap survival area was evaluated on the seventh postoperative day. IPC and pharmacologic preconditioning with morphine, adenosine, and diazoxide (in higher doses; 1, 5, and 15 mg/flap) improved survival area compared with the control group. Glibenclamide abolished their protective effect. K(ATP) channels may have a key role in anti-ischemic properties of IPC and pharmacologic preconditioning.

Publication types

  • Evaluation Study

MeSH terms

  • Adenosine / antagonists & inhibitors
  • Adenosine / pharmacology
  • Adenosine Triphosphate / physiology*
  • Animals
  • Dermatologic Surgical Procedures*
  • Diazoxide / antagonists & inhibitors
  • Diazoxide / pharmacology
  • Glyburide / administration & dosage
  • Glyburide / adverse effects
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / adverse effects
  • Ischemia / prevention & control*
  • Ischemic Preconditioning / methods*
  • Male
  • Morphine / antagonists & inhibitors
  • Morphine / pharmacology
  • Narcotics / pharmacology
  • Potassium Channels / physiology*
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Regional Blood Flow
  • Skin / blood supply*
  • Surgical Flaps / blood supply*
  • Tissue Survival / drug effects
  • Tissue Survival / physiology
  • Vasodilator Agents / antagonists & inhibitors
  • Vasodilator Agents / pharmacology

Substances

  • Hypoglycemic Agents
  • Narcotics
  • Potassium Channels
  • Vasodilator Agents
  • Morphine
  • Adenosine Triphosphate
  • Adenosine
  • Diazoxide
  • Glyburide